Reaction
Neurofibrosarcoma reporting signals
As of the last recalculation, Neurofibrosarcoma appears in 101 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is PAZOPANIB HYDROCHLORIDE (PRR 155.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pazopanib Hydrochloride | 17 | 155.5 | 155.6 |
| Selinexor | 6 | 151.8 | 151.9 |
| Trametinib | 11 | 105.2 | 105.2 |
| Ipilimumab | 14 | 77.4 | 77.5 |